Daridorexant
Back to searchMolecule Structure
Scientific Name
Daridorexant
Description of the Drug
Daridorexant is a dual orexin receptor antagonist used to treat insomnia in adults.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB15031
http://www.drugbank.ca/drugs/DB15031
Brand Name(s)
Not Available
Company Owner(s)
Idorsia Pharmaceuticals Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Orexin receptor 1 | SINGLE PROTEIN | ANTAGONIST | CHEMBL5113 |
| Orexin receptor 2 | SINGLE PROTEIN | ANTAGONIST | CHEMBL4792 |
| Orexin receptor | PROTEIN FAMILY | ANTAGONIST | CHEMBL3307226 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL16778804 | SCHEMBL16766318 |
| DrugBank | DB15031 | |
| PubChem | 91801202 | |
| PDBe | NS2 | |
| BindingDB | 334973 | |
| ChemicalBook | CB04796673 |
